Datacubed Health Launches eClinical Platform App in China, Ensuring Full Compliance and Accessibility

Datacubed Health and AppInChina Forge Strategic Partnership to Launch eClinical Platform in China

New York, New York, Sept. 26, 2023 (GLOBE NEWSWIRE) — Datacubed Health, a leading global provider of innovative solutions for patient engagement and data collection in clinical trials, is excited to announce the official launch of its eClinical platform app in China. This milestone achievement represents a significant step forward for Datacubed Health’s commitment to expanding its presence in the Chinese market.

As part of this strategic move, Datacubed Health has joined forces with AppInChina, a renowned leader in Android App Store publication, ensuring seamless deployment of the eClinical platform app in official Android stores across China and the Apple App Store. This partnership guarantees accessibility to a wide range of devices and ecosystems.

Kyle Hogan, President of Datacubed Health, emphasized the importance of this collaboration: “Our partnership with AppInChina has been instrumental in ensuring the smooth launch of our eClinical platform app in China. This strategic alliance allows us to reach a broader audience while maintaining compliance with local regulations, which is essential for our growth in this market.”

In preparation for this momentous launch, Datacubed Health has established a legal entity within China and acquired all necessary commercial and legal licenses and certificates. These crucial steps are a testament to Datacubed Health’s commitment to providing secure and regulated services within the Chinese market.

Brett Kleger, CEO of Datacubed Health, stated, “Our investment in establishing a legal presence and obtaining the requisite licenses underscores our dedication to operating ethically and responsibly in China. We are focused on delivering cutting-edge solutions while adhering to local regulations and standards.”

Moreover, Datacubed Health has undertaken comprehensive efforts to ensure full software compliance with Chinese regulations. The eClinical platform app for China has been meticulously customized to align with local requirements and has undergone rigorous testing by local quality assurance teams. This meticulous approach ensures the seamless functioning of the platform while adhering to Chinese network security requirements and restrictions.

Datacubed Health has also bolstered its presence in China by establishing a fully compliant and fault-tolerant Software as a Service (SaaS) infrastructure. The Datacubed China solution is now hosted in AWS Beijing, ensuring data security and reliability for users in the region.

With these key developments in operational, legal, and software compliance, Datacubed Health is well-prepared to provide unmatched support to clinical research efforts in China. The launch of the eClinical platform app represents a significant stride in bridging the gap between global research initiatives and the Chinese healthcare landscape.

In the words of CEO Brett Kleger: “We are thrilled to introduce Datacubed Health’s eClinical platform app to the Chinese market. Our partnership with AppInChina, legal entity establishment, and rigorous compliance efforts demonstrate our dedication to providing world-class services to our Chinese users. We look forward to empowering clinical research initiatives in China with our cutting-edge solutions.”

To learn more, we invite you to join us at Booth #24 at the 11th Annual Outsourcing in Clinical Trials Southern California 2023 from September 26-27 in San Diego, California, or visit our website at

About Datacubed Health:

Datacubed Health is a pioneering eClinical technology company built from the ground up by industry veterans who wanted to create a better clinical trial experience for all stakeholders. Our solutions are all infused with neuroeconomic principles designed to be inclusive, drive compliance, and greatly improve retention. We strive to deliver the best experience for you and your patients through ease of use and flexible technology configurable to your needs. Our offerings include a Decentralized Trials Platform, eCOA/ePRO, Patient Engagement, eConsent, Medication Adherence, Televisits, and Geofencing. Learn more at

Media Contact:
Heather Shea
Catalytic Agency for Datacubed Health

Jillian Tygh
Datacubed Health
[email protected]

GlobeNewswire Distribution ID 8926943

Anaqua Builds on its Momentum in Japan with New Leadership, Clients, Solutions and Country HQ

Futoshi Saito Joins as President & General Manager, Japan

BOSTON, Sept. 26, 2023 (GLOBE NEWSWIRE) — Anaqua, the leading global innovation and intellectual property (IP) management technology provider, today announced changes to its executive leadership team in Japan as the company continues its strong growth trajectory in the country. Futoshi Saito will join Anaqua Japan, effective October 10, 2023, as President & General Manager, responsible for driving Anaqua’s ongoing business development and delivering enhanced client solutions in Japan.

Saito-san has previously held leadership positions at LexisNexis as Managing Director, Japan and South Korea, and Thomson Reuters (now part of Clarivate) as head of the IP & Science business in Japan. Saito-san holds a bachelor’s degree in international studies from Dokkyo University and studied at the Graduate School of History at the State University of New York at Albany.

Anaqua also announced the opening of its new Japan headquarters in the TOKYO TORCH Tokiwabashi Tower, providing an expanded work space to support the company’s accelerated growth, which has seen further strengthening of the team and a 50% increase in new sales YTD . The move continues Anaqua Japan’s mission to invest in people, infrastructure and solutions in order to provide clients with the most comprehensive and effective IP management software and solutions in Japan. Other recent Anaqua investments in Japan include opening a second client datacenter on Microsoft Azure, hiring additional team members for the growing annuities and renewals business, and developing Japan-specific enhancements to the AQX IP management platform, both for the pharmaceutical market and trademark professionals.

“I am excited to join Anaqua, a company I have admired for many years over the course of my career in IP and legal technology,” said Saito. “I am honored to lead Anaqua Japan through its next stage of growth and to help our clients better protect and maximize value from their IP portfolios.”

Anaqua CEO Bob Romeo said: “We are delighted to have appointed Saito-san to lead Anaqua’s business in Japan. His extensive IP and technology experience will enable him to engage quickly with our business and the wider market, forming important relationships with our existing and future clients, and providing strong leadership for our team and our further business development. I am very proud of our operations in Japan and I am excited for what is yet to come.”

About Anaqua

Anaqua, Inc. is a premier provider of integrated intellectual property (IP) management technology solutions and services for corporations and law firms. Its IP management software solutions, AQX and PATTSY WAVE, both offer best practice workflows with big data analytics and tech-enabled services to create an intelligent environment designed to inform IP strategy, enable IP decision-making, and streamline IP operations, tailored to each segment’s need. Today, nearly half of the top 100 U.S. patent filers and global brands, as well as a growing number of law firms worldwide use Anaqua’s solutions. Over one million IP executives, attorneys, paralegals, administrators, and innovators use the platform for their IP management needs. The company’s global operations are headquartered in Boston, with offices across the U.S., Europe, and Asia Pacific. For additional information, please visit, or on LinkedIn.

Company Contact:
Kyoko Tsurumi
Associate Director, Marketing and Communications
[email protected]

GlobeNewswire Distribution ID 8927986

SECP Amends AML/CFT Regulations

The Securities and Exchange Commission of Pakistan (SECP) has introduced important amendments to the Anti-Money Laundering and Countering Financing of Terrorism (AML/CFT) Regulations, 2020.

The notified amendments aim to enhance the scope of regulations to effectively combat financial crimes, control money laundering, and combat the financing of terrorism (CFT) while ensuring the integrity of its financial system.

The amendments to the SECP AML/CFT Regulations 2020 are the outcome of the National Risk Assessment 2023, in which SECP conducted a self-assessment of its AML/CFT regulatory framework against the criteria used in the FATF Assessment Methodology for assessing Technical Compliance of its AML/CFT regulatory framework.

In a press statement, SECP said that the amendments, introduced post-stakeholder’s consultation, demonstrate its commitment to enhancing the country’s regulatory framework and aligning it with international best practices.

The amendments to the SECP AML/CFT Regulations 2020 primarily focus on expanding the regulatory framework to encompass measures specifically tailored for Customer Due Diligence (CDD) requirements related to account opening of Mentally Disordered Persons.

Under the revised regulations, an account will be classified as dormant after three years of inactivity, as opposed to the previous threshold of five years. Furthermore, the updated provisions encompass guidelines regarding the reliance on third parties for CDD, as well as specific requirements applicable to the foreign branches of regulated entities and their subsidiaries.

Source: Pro Pakistani

Dr Raja Ali highlights Pakistan’s achievements in peaceful nuclear uses at IAEA conference

Chairman Pakistan Atomic Energy Commission Dr Raja Ali Raza Anwar has said Pakistan remains committed to advance its collaboration with International Atomic Energy Agency its role as per motto, ‘atoms for peace and development’.

He was addressing the 67th session of IAEA general conference in Vienna as the leader of the Pakistan’s delegation.

He stressed that Pakistan views nuclear power as an affordable, reliable and clean source of energy and a part of the solution to the climate crisis.

Source: Radio Pakistan

Pakistan and Germany Sign Convention for Elimination of Double Taxation

The Federal Board of Revenue (FBR) initiated re-negotiations on the Agreement for the elimination of double taxation with respect to taxes on income and the prevention of tax evasion and avoidance between Pakistan and Germany.

In this connection tax delegations of both the countries met at Islamabad for the first round of negotiations from 18-22 September, 2023. The first draft of the Agreement was initialed by the respective heads of delegation on September 22, 2023, in Islamabad after detailed consultations and mutual agreement on key articles of the draft Agreement.

It is pertinent to mention that the existing Agreement for the Avoidance of Double Taxation between Pakistan and Germany in practice was signed in 1994 and requires revision to cater to changing tax rules and regulations as per international and domestic needs.

The revised agreement once finalized will not only strengthen the existing safeguards against double taxation on the income of the residents of both countries without creating opportunities for non-taxation or reduced taxation through abusive arrangements.

It will also promote economic cooperation, strengthen the existing bilateral economic relations, and enhance investments in both countries while ensuring adequate certainty with respect to taxation rules applicable to cross-border business transactions. Taxpayers of both countries will get relief from double taxation resulting in boosting the trading activities in both countries.

Source: Pro Pakistani